[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581078":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":19,"locations":20,"responsibleParty":44,"collaborators":46,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":19,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":19,"enrollmentInfo":59,"targetDuration":19,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":68,"overallStatus":23,"whyStopped":19,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Curonix LLC","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational","EXPERIMENTAL","observational",[13],"Device: PNS device, observational study, no intervention during study",[15],{"type":16,"name":17,"description":17,"armGroupLabels":18,"otherNames":19},"DEVICE","PNS device, observational study, no intervention during study",[9],null,[21],{"facility":22,"status":23,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"The Metrohealth System","RECRUITING","Cleveland","Ohio","44109","United States","US",{"type":30,"coordinates":31},"Point",[32,33],-81.69541,41.4995,{"lat":33,"lon":32},[36,41],{"name":37,"role":38,"phone":39,"phoneExt":19,"email":40},"Samantha Pope","CONTACT","216-778-1270","Spope1@metrohealth.org",{"name":42,"role":43,"phone":19,"phoneExt":19,"email":19},"Brendan Astley, MD","PRINCIPAL_INVESTIGATOR",{"type":45,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR",[47],{"name":48,"class":49},"MetroHealth System, Ohio","OTHER","100581078","retrospective-prospective-pns-study-100581078",false,"NCT06845631","Retrospective-Prospective PNS Study","Retrospective-Prospective Clinical Trial Investigating the Treatment of Chronic Pain With the Freedom Peripheral Nerve Stimulation System","Inclusion Criteria:\n\nA. Subject is ≥ 18 years of age at time permanent implant; B. Subject has been implanted with the Freedom PNS system; C. Subject is willing to attend visit as scheduled, and comply with the study requirements (if prospective); D. Patient is capable of giving informed consent.\n\nExclusion Criteria:\n\nA. Subject is currently enrolled in or plans to enroll in any concurrent drug and\u002For device study while participating in this study (if prospective); B. Any additional active implanted devices for the treatment of chronic pain in addition to the Freedom PNS system.","ALL","18 Years",{"count":60,"type":61},40,"ESTIMATED","INTERVENTIONAL",[64],"NA","This is a retrospective-prospective study in which 40 patients have received a permanent Freedom PNS System. Subjects presented with chronic, intractable pain of peripheral nerve origin refractory to standard medical and\u002For surgical treatment.\n\nA retrospective chart review will be conducted to assess baseline and follow-up parameters in patients who have received a permanent implant with the Freedom PNS system for at least 12 months. Missing data might be collected after informed consent.",[67],"Chronic Pain",[69],"chronic pain, PNS, Retrospective, prospective","2025-02-24",{"date":72,"type":73},"2025-02-25","ACTUAL",{"date":75,"type":73},"2024-07-01",{"date":77,"type":61},"2026-12-01",{"name":5,"class":6},1]